D3A.093
Benign carcinoid tumor of the kidney
Clinical Classification Guidelines
Medical Intelligence & Overview
A benign carcinoid tumor of the kidney is a rare, non-cancerous growth that originates from specialized nerve cells called neuroendocrine cells in the kidney. While tumors in this category are more commonly found in organs such as the lungs and gastrointestinal tract, their occurrence in the kidney is exceptionally uncommon. Understanding this condition helps in recognizing symptoms and understanding the typical management approach, though the outlook is generally positive due to the benign nature of the tumor.
Causes & Symptoms
Clinical Causes: The precise causes of benign carcinoid tumors in the kidney are not well understood. They are thought to develop from abnormal growths of neuroendocrine cells, but why these cells become overgrown and form tumors in the kidney remains unclear. Factors such as genetic mutations may play a role, but research is ongoing. It's important to note that benign carcinoid tumors are distinct from malignant ones and have a very low potential for spreading or causing serious health complications.
Key Symptoms: Many individuals with a benign carcinoid tumor of the kidney may not experience symptoms and might discover the tumor incidentally during imaging tests for unrelated issues. When symptoms do occur, they may include: - Flank pain or discomfort in the side of the abdomen - A lump or mass felt in the area of the kidney - Unexplained weight loss - Fatigue or weakness - Hematuria, which is blood in the urine - In rare cases, symptoms related to hormone production by the tumor, such as flushing or diarrhea, may appear, though these are uncommon with benign tumors. Because symptoms are often non-specific, regular medical evaluations and imaging studies are crucial for detection.
Diagnostic & Treatment
Diagnosis Path: Diagnosing a benign carcinoid tumor of the kidney involves several steps: - Medical history review and physical examination - Imaging studies such as ultrasound, CT scans, or MRI to visualize the kidney and detect any abnormal masses - Biopsy, which involves taking a small tissue sample for microscopic examination to confirm the tumor’s benign nature - Laboratory tests, if hormone secretion symptoms are present, to assess any functional activity of the tumor An accurate diagnosis is important to differentiate benign carcinoid tumors from other types of kidney masses, including malignant tumors.
Treatment Protocols: Treatment options for a benign carcinoid tumor of the kidney primarily focus on removal of the tumor while preserving as much normal kidney tissue as possible. Approaches include: - Surgical removal, often through partial nephrectomy, which involves excising just the tumor and a small margin of healthy tissue - Complete removal of the affected kidney in rare cases where the tumor is large or difficult to access - Monitoring, in cases where the tumor is small, asymptomatic, and confirmed to be benign, with regular follow-up imaging to observe for any changes Because these tumors are benign, extensive treatments like chemotherapy or radiation are typically unnecessary. The prognosis after removal or control is generally excellent, with low chances of recurrence or complications.
Clinical Advice & FAQs
Billing Guidance
Is D3A.093 a billable ICD-10 code?
Yes, D3A.093 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D3A.093?
Clinical documentation must specify the nature of Benign carcinoid tumor of the kidney and any associated comorbidities for accurate reporting.
Cite this Clinical Reference